Page last updated: 2024-09-05

org 31710 and u 0126

org 31710 has been researched along with u 0126 in 1 studies

Compound Research Comparison

Studies
(org 31710)
Trials
(org 31710)
Recent Studies (post-2010)
(org 31710)
Studies
(u 0126)
Trials
(u 0126)
Recent Studies (post-2010) (u 0126)
38362,81621,213

Protein Interaction Comparison

ProteinTaxonomyorg 31710 (IC50)u 0126 (IC50)
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.29
Serine/threonine-protein kinase B-rafHomo sapiens (human)0.25
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)0.07
Dual specificity mitogen-activated protein kinase kinase 2Homo sapiens (human)0.2816
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)0.2529

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, LC; Hsu, SP; Huo, YN; Kuo, CT; Lee, WS; Wen, HC; Yang, HC1

Other Studies

1 other study(ies) available for org 31710 and u 0126

ArticleYear
Progesterone receptor-NFκB complex formation is required for progesterone-induced NFκB nuclear translocation and binding onto the p53 promoter.
    Endocrinology, 2015, Volume: 156, Issue:1

    Topics: Active Transport, Cell Nucleus; Butadienes; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Estrenes; Flavonoids; Furans; Gene Expression Regulation; Hormone Antagonists; Humans; Mifepristone; NF-kappa B; Nitriles; Progesterone; Promoter Regions, Genetic; Protein Binding; Receptors, Progesterone; Sulfones; Tumor Suppressor Protein p53

2015